SoftBank-backed Delhivery contests metrics in rival Ecom Express’ IPO filing

Date:

Share post:


Indian logistics firm Delhivery has publicly contested the accuracy of metrics presented by competitor Ecom Express in its draft initial public offering prospectus, a rare confrontation in the lead-up to the latter’s market debut. 

Delhivery, which is backed by SoftBank and already publicly listed, claims that Ecom Express has inaccurately represented Delhivery’s business metrics when drawing comparisons in its IPO filing. 

The 442-page draft prospectus (PDF) submitted by Ecom Express last month reported that the startup had shipped 514.41 million packages in the fiscal year ending March 2024, while Delhivery handled 740 million during the same period. 

Delhivery alleged in a filing to the stock exchanges Friday that this comparison is flawed, asserting that what it considers a single shipment is counted as two by its rivals, suggesting that Ecom Express’s volume figures are potentially inflated. (Delhivery says that its rivals count an order returned as two shipments.)

Delhivery further contests Ecom Express’s cost per shipment (CPS) calculations, citing disparities in accounting methods and alleging inflated shipment figures.

A slide from Delhivery’s filing Friday. (Image: Delhivery/BSE)

This public dispute comes less than a month after Ecom Express, which counts Warburg Pincus, Partners Group, and British International Investment among its backers, filed for an IPO aiming to raise $310 million. 

Delhivery has also questioned Ecom Express’s presentation of service EBITDA and corporate costs, citing a lack of consistent definitions for these metrics in the prospectus.

Ecom Express didn’t immediately respond to a request for comment.

This is a developing story. More to follow.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

OneRail’s software helps solve the last-mile delivery problem

Last-mile delivery, the very last step of the delivery process, is a common pain point for companies....

Bill to ban social media use by under-16s arrives in Australia’s parliament

Legislation to ban social media for under 16s has been introduced in the Australian parliament. The country’s...

Lighthouse, an analytics provider for the hospitality sector, lights up with $370M at a $1B valuation

Here is yet one more sign of the travel industry’s noticeable boom: a major growth round for...

DOJ: Google must sell Chrome to end monopoly

The United States Department of Justice argued Wednesday that Google should divest its Chrome browser as part...

WhatsApp will finally let you unsubscribe from business marketing spam

WhatsApp Business has grown to over 200 million monthly users over the past few years. That means there...

OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI

Cancer, one of the most life-threatening diseases, is projected to affect over 35 million people worldwide in...

India’s Arzooo, once valued at $310M, sells in distressed deal

Arzooo, an Indian startup founded by former Flipkart executives that sought to bring “best of e-commerce” to...

OpenAI accidentally deleted potential evidence in NY Times copyright lawsuit

Lawyers for The New York Times and Daily News, which are suing OpenAI for allegedly scraping their...